Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapiesMichael E. Lidsky, Kris C. Wood, Kouros Owzar et al.|npj Precision Oncology|2022Cited by 17
Cooperative regulation of coupled oncoprotein synthesis and stability in triple-negative breast cancer by EGFR and CDK12/13Hazel X. Ang, Kris C. Wood, Natalia Sutiman et al.|Proceedings of the National Academy of Sciences|2023Cited by 16
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancersDaniel P. Nussbaum, Kris C. Wood, Colin A. Martz et al.|npj Precision Oncology|2024Cited by 6
Integrative <i>PTEN</i> Enhancer Discovery Reveals a New Model of Enhancer OrganizationChristian Cerda-Smith, Kris C. Wood, Haley M. Hutchinson et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 5